These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4408096)

  • 21. Binding of sulfonylurea derivatives to bovine serum albumin: part I. Binding of SPC--703, tolbutamide, glibornuride and glipizide.
    Wójcikowski C; Szlabowicz D
    Pol J Pharmacol Pharm; 1977; 29(5):469-75. PubMed ID: 22846
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacokinetica and metabolism of phenprocoumon--"marcumar" in man].
    Glogner P; Heni N
    Verh Dtsch Ges Inn Med; 1973; 79():1308-11. PubMed ID: 4790166
    [No Abstract]   [Full Text] [Related]  

  • 23. Binding study of sulfonylureas and phenothiazines to bovine serum albumin using difference spectrophotometry.
    Zia H; Price JC
    J Pharm Sci; 1975 Jul; 64(7):1177-81. PubMed ID: 1171217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of glipizide with human serum albumin.
    Crooks MJ; Brown KF
    Biochem Pharmacol; 1975 Jan; 24(2):298-9. PubMed ID: 234237
    [No Abstract]   [Full Text] [Related]  

  • 25. Complex formation between macromolecules and drugs. X. Binding of tolbutamide, chlorpropamide and carbutamide to human serum albumin, and the competition between tolbutamide or chlorpropamide and carbutamide or 4-sulfanilamido-2,6-dimethylpyrimidine for binding sites on human serum albumin.
    Nilsson B; Agren A
    Acta Pharm Suec; 1974 Sep; 11(4):391-400. PubMed ID: 4412551
    [No Abstract]   [Full Text] [Related]  

  • 26. [Behavior of serum insulin under the influence of glisoxepide with and without butylbiguanide].
    Birk W; Petrides P
    Arzneimittelforschung; 1974 Mar; 24(0):425-9. PubMed ID: 4408033
    [No Abstract]   [Full Text] [Related]  

  • 27. Insulinotrophic drugs. Effect on intestinal abosorption of sugar.
    Botros M; Selim R; Ghoneim K; Ghareeb A; Wahba N
    Diabetes; 1974 Feb; 23(2):112-6. PubMed ID: 4204422
    [No Abstract]   [Full Text] [Related]  

  • 28. Interactions of sulfonylureas with plasma proteins.
    Hsu PL; Ma JK; Luzzi LA
    J Pharm Sci; 1974 Apr; 63(4):570-3. PubMed ID: 4208196
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmacological interference of glibornuride with sulfaphenazole, phenylbutazone, and phenprocoumon in man].
    Eckhardt W; Rudolph R; Sauer H; Schubert WR; Undeutsch D
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2212. PubMed ID: 4679251
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug interactions of gliclazide and other sulfonylureas in protein binding in vitro and in hypoglycemic effect in rats.
    Fujii T; Nakamura K; Furukawa H; Watanabe M; Kuwashima J; Miyazaki H; Kawashima K; Kuzuya T
    Arzneimittelforschung; 1983; 33(11):1535-7. PubMed ID: 6686448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of colestipol, a new bile acid sequestrant, on the absorption of phenprocoumon in man.
    Harvengt C; Desager JP
    Eur J Clin Pharmacol; 1973 Jun; 6(1):19-21. PubMed ID: 4764368
    [No Abstract]   [Full Text] [Related]  

  • 33. Nuclear magnetic resonance study of the binding of tolbutamide and chlorpropamide to bovine serum albumin.
    Ueda H; Higashiyama K; Nagai T
    Chem Pharm Bull (Tokyo); 1980; 28(4):1016-21. PubMed ID: 7418103
    [No Abstract]   [Full Text] [Related]  

  • 34. [Binding of sulfonylureas to bovine serum albumin (author's transl)].
    Goto S; Yoshitomi H; Kishi M
    Yakugaku Zasshi; 1977 Nov; 97(11):1219-27. PubMed ID: 616823
    [No Abstract]   [Full Text] [Related]  

  • 35. Displacement of tolbutamide, glibencalmide and chlorpropamide from serum albumin by anionic drugs.
    Brown KF; Crooks MJ
    Biochem Pharmacol; 1976 May; 25(10):1175-8. PubMed ID: 820348
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical experience with the blood sugar reducing sulfonamide derivative glisoxepide].
    Petzoldt R; Riedesel G; Ramrath M; Grabs V; Haupt E; Schwedes U; Ewald W; Beyer J; Schöffling K
    Arzneimittelforschung; 1974 Mar; 24(0):429-32. PubMed ID: 4603399
    [No Abstract]   [Full Text] [Related]  

  • 37. The binding of aflatoxin B1 with serum albumin.
    Bassir O; Bababunmi EA
    Biochem Pharmacol; 1973 Jan; 22(1):132-4. PubMed ID: 4763240
    [No Abstract]   [Full Text] [Related]  

  • 38. [The toxicology of glisoxepide, a new oral antidiabetic. Results of animal studies].
    Tettenborn D
    Arzneimittelforschung; 1974 Mar; 24(0):409-18. PubMed ID: 4408138
    [No Abstract]   [Full Text] [Related]  

  • 39. [Liquid chromatography frontal analysis of the protein binding of glimepiride].
    Zhou DW; Wang HF; Li FM
    Yao Xue Xue Bao; 2005 Jan; 40(1):39-42. PubMed ID: 15881325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circular dichroism studies on the interaction of sulfonylureas with bovine and human serum albumin.
    Müller WE; Wollert U
    Res Commun Chem Pathol Pharmacol; 1976 Mar; 13(3):551-4. PubMed ID: 819976
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.